(6-{2-[3-(4-Benzyloxy-phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl}-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester

• Catalog No.: B287652
• CAS Number: 265989-37-5
• M. F.: C47H53FN2O6
• M. W.: 760.9319232

SYNONYMS

• IUPAC name: tert-butyl 2-[(4R,6R)-6-[2-(3-{[4-(benzyloxy)phenyl]carbamoyl}-5-(4-fluorophenyl)-4-(^2H₅)phenyl-2-(propan-2-yl)-1H-pyrrol-1-yl)ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate
• IUPAC Traditional name: tert-butyl 2-[(4R,6R)-6-[2-(3-{[4-(benzyloxy)phenyl]carbamoyl}-5-(4-fluorophenyl)-2-isopropyl-4-(^2H₅)phenylpyrrol-1-yl)ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate
• Synonyms: (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-(phenyl-d5)-4-[[[4-(phenylmethoxy)phenyl]amino]carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic Acid 1,1-Dimethylethyl Ester

DATABASE IDS

• CAS Number: 265989-37-5

PROPERTIES

• Apperance: Light-Pink Solid
• Solubility: Acetone
• Solubility: Chloroform
• Solubility: Dichloromethane
• Solubility: Ethyl Acetate

DETAILS

Description (English)

A deuterated intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with